AAF investigators brought six new drugs to clinical trials and many
more potential therapies are in the pipeline.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to
more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and
potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell
therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other
therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
MMRF and Memorial Sloan Kettering to launch a new clinical trial to identify
potential genomic markers linked to achieving and maintaining deep response to
therapy Read
More
The finding offers
potential for developing both gene
therapy and
more effective protein replacement treatments for hemophilia A, the most common form of hemophilia.
The current study was designed to clarify the cellular hierarchy underlying glioblastoma, to identify epigenetic factors that distinguish glioblastoma stem cells from
more differentiated tumor cells and to suggest
potential therapies targeting those factors.
«Unsuspected characteristics of new cystic fibrosis drugs found, offering
potential paths to
more effective
therapies.»
The study paves the way for CRISPR - Cas9 as a powerful gene editing tool with
potential therapeutic applications for inherited diseases — leading to
more widely available gene
therapy techniques.
The same process has been studied as a
potential genetic
therapy for
more than a decade, because you can target any disease gene with matching dsRNA.
Hooker and Van de Bittner note, however, that the tool also has tremendous
potential for research applications, particularly for drug discovery in smell - loss
therapy and in understanding the relationships between olfactory neuron health and brain health
more generally.
In contrast, applied research needs to contribute to a product or
therapy, which means that research projects which don't show
potential will be dropped to give attention to
more promising ones.
However, another way of getting at a similar end - and one with
more potential as a
therapy - is to find out what the plasticity brake is acting on, and try to artificially boost the process being suppressed.
By tracking and understanding which host cell pathways are manipulated by these T. gondii proteins, scientists can identify
potential new targets to develop
more effective
therapies against highly aggressive solid tumors.
Analyzing
more than 120 million patient records and identifying trends of co-occurrence among hundreds of diseases, they created a unique genetic map that has the
potential to guide researchers and clinicians in diagnosing, identifying risk factors for and someday developing
therapies against complex diseases.
The findings, described in his prize - winning essay,» Refining cell
therapy,» could eventually help overcome the major hurdles that currently hinder T cell immunotherapies from reaching their full
potential, and offer patients
more favorable treatment outcomes.
The
more we know about the steps that occur in disease progression, the
more opportunities we have to intervene with
potential therapies.»
Saez and his colleagues will next focus on using the new screening strategy to uncover
more biological pathways that could yield new mechanisms to develop
potential therapies.
More niche
therapies are in development, which means the
potential pool of study participants is diminishing.
Although there remains no cure for Alzheimer's, researchers hope that testing
potential drugs or
therapies prior to mental decline will prove to be
more successful than previous attempts at finding the most effective treatment in the battle against the debilitating disease.
Professor Winder's approach could complement
potential therapies currently advancing through clinical trials, making them
more effective.
DMAbs, which are produced in the body, have the
potential to overcome many of these limitations, reducing cost barriers that would allow such technologically advanced
therapies to reach
more populations around the globe.
«
More research is being conducted with VNA gene
therapy and it's hard to deny the
potential of this rapid - acting and long - lasting
therapy in treating these and several other important illnesses.»
WGS currently requires significantly
more manual analysis, so combining this method with artificial intelligence could help doctors identify
potential therapies from WGS for
more patients in less time.
«It suggests to us that targeting the pathways used in regulating cell fate decisions — how stem cells choose between cell proliferation and differentiation — could be a
more effective way of halting tumours in their tracks and lead to
potential new
therapies.»
After hearing a brief explanation that laid out the different sources of stem cells (but left undiscussed their current uses or future
potential for
therapy), the respondents offered a slightly
more nuanced set of views, and only a slight majority (52 %) supported embryonic stem cell research.
With cellular
therapy holding enormous promise for future cures and treatments, Black Beret Life Sciences is committed to doing what it can to help the field reach its full medical
potential by creating a
more efficient regulatory framework in the U.S.
Yamanaka said, «We hope that further trials of iPSC - based
therapies, accompanied by basic research focused on gaining
more detailed, molecular insights into the process of cellular reprogramming itself, will result in unveiling the full
potential of iPSCs in the next decade.
University of California San Francisco researchers may have discovered why the experimental anti-cancer drug Onyx - 015 works
more broadly than had been expected, a finding that could solidify and expand use of the drug and which reveals a
potential new target for
therapy that could prompt the development of other cancer drugs.
By considering patient experiences and feedback, researchers and advocates alike can learn
more about the safety and efficacy of
potential stem cell
therapies.
«Our findings of this
potential biomarker are exciting — it means we are closer to being able to select
therapies more specifically for a patient with colon cancer.
Although researchers are excited about the
potential to use CRISPR to create
therapies from people's own blood, immune, and stem cells, thousands
more genetic conditions affect everything else.
4/7/2008 From Bench to Bedside in One Year: Stem Cell Research Leads to
Potential New
Therapy for Rare Blood Disorder A unique partnership between industry and academia has led to human clinical trials of a new drug for a rare class of blood diseases called myeloproliferative disorders (MPD), which are all driven by the same genetic mutation and can evolve into leuk...
More...
They provide a new target for
potential therapies, and they furnish a model system for
more rapid and less expensive study of prion diseases and
potential treatments.
Once the future stem cell therapist does the
therapy, stem cells have the innate
potential to produce
more cells.»
This will create strong synergy for a unified, multidimensional project aimed at generating
more effective CAR T cells
therapy for pancreatic cancer patients, with
potential broad implications for immunotherapy directed toward other cancers.
Thanks to all of this, today there is
more talk about how one goes from basic science observations to
potential therapies.
Learn
more about the
potential benefits of cell
therapy for chronic conditions here.
Although recently approved
therapies can increase progression - free survival by a few months, «we think this novel screening system has the
potential to uncover new,
more effective medications that could be targeted
more specifically at a patient's cancer,» Lengyel said.
Methotrexate and cyclosporine clear psoriasis
more quickly than Soriatane, for instance, but are less appropriate for long - term «maintenance»
therapy due to the
potential for liver and kidney damage.
Given the high risk of side effects from antidepressants, one may only hope that
more doctors and health professionals will begin to look into the
potential of using yoga as
therapy to combat depression in kids, to give them a safe and effective way to help combat the heavy burden of hopelessness and inertia that all - too - often accompany depression in youth.
One of the
more unappealing
potential side effects of testosterone
therapy is gynecomastia.
It goes through in detail various
potential sources of error and bias (e.g. manner and timing of reporting of weight, mammography, high risk vs average population, cancer subtypes, hormone
therapies, etc) that may be confounding results, and relates results of previous studies to those of a
more recent study which attempted to correct for some of these errors.
The past century has unveiled a plethora of preclinical data that has suggested the
potential of a ketogenic diet as an aid in cancer treatment.7, 8 The benefits of a ketogenic diet, and dietary manipulation in general, may be a potent adjunct to current cancer treatments by synergistically working with chemotherapy and radiation
therapy to starve cancer cells, leaving them
more susceptible to damage from these treatments.7 - 10
Here you'll discover stories from the Special Yoga team and our practitioners that give you an insight into what we do and the wonderful community of people we support.We provide Special Yoga
therapy to kids with special needs and offer certified teacher training to help
more children embrace their
potential Frequency about 2 posts per month Since Jan 2015 Website specialyoga.org.uk / blog + Follow Facebook fans - 12,504.
Here you'll discover stories from the Special Yoga team and our practitioners that give you an insight into what we do and the wonderful community of people we support.We provide Special Yoga
therapy to kids with special needs and offer certified teacher training to help
more children embrace their
potential Frequency about 2 posts per month Since Jan 2015 Website specialyoga.org.uk / blog + Follow Facebook fans - 12,504.
In November in Albuquerque, NM,
more than 60 participants attended this interactive panel «Art
Therapy in Urban Settings: Problems,
Potentials, Possibilities» that addressed the growing problems therapists and educators encounter in urban schools and regular / self - contained classrooms.
found that slightly
more than a third of medical practices are effective or likely to be effective; 15 % are harmful, unlikely to be beneficial, or a tradeoff between benefits and harms; and 50 % are of unknown effectiveness...»... One surprising type of reversal we observed was potentially beneficial
therapies being withheld because of unfounded concerns about their
potential to cause harm.»
Personally, I have always seen
therapy to be
more of a intense joint partnership focused on a client's personal achievement, exploration of their untapped
potential and opportunities and utilizing their strengths to balance them out.
Frequently, a client's current difficulties have developed over a long period of time, and during the course of
therapy a deepened understanding of the roots of these problems increases a client's
potential to experience positive change, increased self - esteem, strengthened confidence and
more satisfying relationships.»
The struggle to meet the increasing demand for psychological
therapies, particularly during financial downturns, has driven interest in how
therapies can be delivered
more efficiently and effectively.3 Computerised cognitive behaviour
therapy (cCBT) is a rapidly advancing field that has been recommended within National Institute for Health and Care Excellence (NICE) clinical guidelines for depression.4 Proponents of cCBT have highlighted increased access for patients and the
potential of these treatments to empower patients, 5, 6 while others have been sceptical that
therapy can work in the absence of a therapeutic relationship with a professional.7
It prevents accurate monitoring of abuse
potential, as the victim is likely to be afraid to report honestly if the
potential is high, and it may cause
more violence after
therapy has stirred troublesome emotions and conversations or if the victim reports the abuser's actions honestly.